Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer.

about

Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer.

P2860

Q55285429-3430737C-3AC9-4DEB-BDED-ECA4E15FF23D

P2860

Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer.

Item

http://www.wikidata.org/entity/Q50223454

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tuning polypeptide-based micel ...... ErbB2-positive breast cancer.

@en

Tuning polypeptide-based micel ...... ErbB2-positive breast cancer.

@nl

type

Item

label

Tuning polypeptide-based micel ...... ErbB2-positive breast cancer.

@en

Tuning polypeptide-based micel ...... ErbB2-positive breast cancer.

@nl

prefLabel

Tuning polypeptide-based micel ...... ErbB2-positive breast cancer.

@en

Tuning polypeptide-based micel ...... ErbB2-positive breast cancer.

@nl

P1476

Tuning polypeptide-based micel ...... ErbB2-positive breast cancer.

@en

P2093

Fan Lei

http://www.w3.org/2001/XMLSchema#string

Kruti S Soni

http://www.w3.org/2001/XMLSchema#string

Luis A Marky

http://www.w3.org/2001/XMLSchema#string

Samuel M Cohen

http://www.w3.org/2001/XMLSchema#string

Swapnil S Desale

http://www.w3.org/2001/XMLSchema#string

Tatiana K Bronich

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition

Drug combination studies and their synergy quantification using the Chou-Talalay method

Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.

Block Ionomer Complex Micelles with Cross-Linked Cores for Drug Delivery.

Nonionic Block Copolypeptide Micelles Containing a Hydrophobic racemic-Leucine Core.

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors a

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.

P304

276-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2017.08.038

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

264

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28870832

http://www.w3.org/2001/XMLSchema#string

P932

5632592

http://www.w3.org/2001/XMLSchema#string

Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer.

about

P2860

P2860

Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932